A woman with fever and rash after African Safari

Clinical Infectious Diseases

Volumn 43, Issue 5, 2006, Pages

  Uslan, Daniel Z ^a   Jacobson, Kurt M ^a   Kumar, Neeraj ^a   Berbari, Elie F ^a   Orenstein, Robert ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELARSOPROL; PENTAMIDINE; PREDNISONE; SURAMIN;

AFRICA; AFRICAN TRYPANOSOMIASIS; ARTICLE; CASE REPORT; FEMALE; FEVER; HUMAN; LEUKOCYTE COUNT; LUMBAR PUNCTURE; PATIENT MONITORING; PRIORITY JOURNAL; RASH; TRAVEL; TRYPANOSOMA BRUCEI;

EID: 33747596918     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/506447     Document Type: Article

References (11)

1. Pepin J, Milord F, Guern C, Mpia B, Ethier L, Mansinsa D. Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in gambiense sleeping sickness. Lancet 1989; 1:1246-50.
2. Pepin J, Milord F, Khonde AN, et al. Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness. Trans R Soc Trop Med Hyg 1995; 89:92-7.
3. Stich A, Abel PM, Krishna S. Human African trypanosomiasis. BMJ 2002; 325:203-6.
4. McGovern TW, Williams W, Fitzpatrick JE, Cetron MS, Hepburn BC, Gentry RH. Cutaneous manifestations of African trypanosomiasis. Arch Dermatol 1995; 131:1178-82.
5. Ripamonti D, Massari M, Arici C, et al. African sleeping sickness in tourists returning from Tanzania: the first 2 Italian cases from a small outbreak among European travelers. Clin Infect Dis 2002; 34:E18-22.
6. Moore DA, Edwards M, Escombe R, et al. African trypanosomiasis in travelers returning to the United Kingdom. Emerg Infect Dis 2002; 8:74-6.
7. Moore AC, Ryan ET, Waldron MA. Case 20-2002: A 37-year-old man with fever, hepatosplenomegaly, and a cutaneous foot lesion after a trip to Africa. N Engl J Med 2002; 346:2069-76.
8. Kennedy PG. Human African trypanosomiasis of the CNS: current issues and challenges. J Clin Invest 2004; 113:496-504.
9. World Health Organization (WHO). Control and surveillance of African trypanosomiasis: report of a WHO expert committee. Geneva, Switzerland: WHO, 1998.
10. Lejon V, Legros D, Richer M, et al. IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test. Trop Med Int Health 2002; 7:685-92.
11. Legros D, Ollivier G, Gastellu-Etchegorry M, et al. Treatment of human African trypanosomiasis: present situation and needs for research and development. Lancet Infect Dis 2002; 2:437-40.